CTXR Morning Update + This Game-Changer Green Wave Stock Could Be Tomorrow's Big Breakout Idea (Low Float)
Full Report Release - 4:00PM EST Today
Key Instructions Below: Sign-up Info For My SMS Updates
Huge news was released yesterday on Monday's stock profile (CTXR). Check out the press here.
CTXR continues to hit milestones in their Phase 3 trial. Up next in the Mino-Lok trial is the 75% interim analysis for superior efficacy and is expected in first half of 2020.
With each major milestone hit, Mino-Lok has the potential to change the standard of care for the management of serious infections in catheters. The market potential for an effective antibiotic lock therapy is estimated to be $750+Mn per year in the U.S. and approximately $1.5Bn worldwide.
Keep CTXR on your radar moving forward.
On the hunt for your next big breakout idea, I've discovered a stock that looks like its starting to heat up for a big-time run.
Recently, the company announced it would be switching directions, yet, it appears that Wall Street has not picked up on this fact.
This could be major situation for traders looking for an under-the-radar stock with tons of upside potential.
For one, the Brightfield Group reports that CB sales in the US are projected to grow from approximately $600Mn in 2018 to $23.7Bn by 2023.
The company (whose full report I'm bringing to you at 4:00PM EST today) wants to tap into this booming market and thinks there's no better time than to get started now.
Plus, with it being in the infancy of this new movement, any bit of good news could set this low float stock running hard (under 5Mn shares in float).
So, to make sure you get my full report later this afternoon, don't take any chances. Do this: